Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yugo Matsumura

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Toxics|March 27, 2026
Impact of Plasticizers on the Microbial Degradation of Polyhydroxybutyrate (PHB)Yan Zhao, Yugo Matsumura, Peng-Cheng Zhao, et al.
Medicine|July 15, 2025
Successful pembrolizumab treatment in a patient with ALK-positive lung adenocarcinoma: A case report and literature reviewYugo Matsumura, Seiya Ichihara, Kaori Nii, et al.
Respiratory Medicine Case Reports|May 28, 2024
A case of pleural mesothelioma with immunohistochemical staining positive for Krebs von den Lungen-6Yugo Matsumura, Seidai Sato, Keiko Haji, et al.
Cancer Reports (Hoboken, N.J.)|July 7, 2025
First-Line Osimertinib for EGFR-Mutated Squamous Cell Lung Carcinoma: A Case ReportYugo Matsumura, Seiya Ichihara, Kaori Nii, et al.
Thoracic Cancer|December 17, 2024
Pathological Complete Response to a Single Dose of Pembrolizumab-Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case ReportYugo Matsumura, Seiya Ichihara, Kaori Nii, et al.
Respiratory Medicine Case Reports|July 19, 2024
Transformation of <i>epidermal growth factor receptor</i> mutated lung adenocarcinoma to small-cell carcinoma long after the cessation of tyrosine kinase inhibitor treatment: A case series and literature reviewKenya Miyamoto, Hirokazu Ogino, Takumi Kakimoto, et al.
International Journal of Clinical Oncology|July 15, 2024
Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancerYuki Tsukazaki, Hirokazu Ogino, Yoshio Okano, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Toxics|March 27, 2026
Impact of Plasticizers on the Microbial Degradation of Polyhydroxybutyrate (PHB)Yan Zhao, Yugo Matsumura, Peng-Cheng Zhao, et al.
Medicine|July 15, 2025
Successful pembrolizumab treatment in a patient with ALK-positive lung adenocarcinoma: A case report and literature reviewYugo Matsumura, Seiya Ichihara, Kaori Nii, et al.
Respiratory Medicine Case Reports|May 28, 2024
A case of pleural mesothelioma with immunohistochemical staining positive for Krebs von den Lungen-6Yugo Matsumura, Seidai Sato, Keiko Haji, et al.
Cancer Reports (Hoboken, N.J.)|July 7, 2025
First-Line Osimertinib for EGFR-Mutated Squamous Cell Lung Carcinoma: A Case ReportYugo Matsumura, Seiya Ichihara, Kaori Nii, et al.
Thoracic Cancer|December 17, 2024
Pathological Complete Response to a Single Dose of Pembrolizumab-Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case ReportYugo Matsumura, Seiya Ichihara, Kaori Nii, et al.
Respiratory Medicine Case Reports|July 19, 2024
Transformation of <i>epidermal growth factor receptor</i> mutated lung adenocarcinoma to small-cell carcinoma long after the cessation of tyrosine kinase inhibitor treatment: A case series and literature reviewKenya Miyamoto, Hirokazu Ogino, Takumi Kakimoto, et al.
International Journal of Clinical Oncology|July 15, 2024
Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancerYuki Tsukazaki, Hirokazu Ogino, Yoshio Okano, et al.
Pageof 1